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Objective To evaluate a calibration method for disk diffusion antibiotic susceptibility
tests, using zone diameter values generated in the individual laboratory as the internal
calibrator for combinations of antibiotic and bacterial species.
Methods The high-zone side of zone histogram distributions was first analyzed by
moving averages to determine the peak position of the susceptible population. The
accumulated percentages of isolates for the high zone diameter values were calculated
and converted into probit values. The normal distribution of the ideal population of
susceptible strains was then determined by using the least-squares method for probit
values against zone diameters, and the ideal population was thereby defined, including
mean and standard deviation. Zone diameter values were obtained from laboratories at
the Karolinska Hospital (KS) and Va¨xjo¨ Hospital (VX), and from two laboratories (LabA,
LabB) in Argentina. The method relies on well standardized disk tests, but is independent
of differences in MIC limits and zone breakpoints, and does not require the use of
reference strains. Resistance was tentatively set at below 3 SD from the calculated, ideal
mean zone diameter of the susceptible population.
Results The method, called normalized interpretation of antimicrobial resistance, was
tested on results from the KS and VX clinical microbiology laboratories, using the disk
diffusion method for antimicrobial susceptibility tests, and for two bacterial species,
Staphylococcus aureus and Escherichia coli. In total, 114 217 test results were included for the
clinical isolates, and 3582 test results for control strains. The methodology at KS and VX
followed the standard of the Swedish Reference Group for Antibiotics (SRGA). Zone
diameter histograms for control strains were first analyzed to validate the procedure, and
a comparison of actual means with the calculated means showed a correlation coefficient
of r¼ 0.998. Results for clinical isolates at the two laboratories showed an excellent
agreement for 54 of 57 combinations of antibiotic and bacterial species between normalized
interpretations and the interpretations given by the laboratories. There were difficulties
with E. coli and mecillinam, and S. aureus and tetracycline and rifampicin. The method was
also tested on results from two laboratories using the NCCLS standard, and preliminary
results showed very good agreement with quality-controlled laboratory interpretations.
Conclusions The normalized resistance interpretation offers a new approach to com-
parative surveillance studies whereby the inhibition zone diameter results from disk tests
in clinical laboratories can be used for calibration of the test.
Keywords Antibiotic susceptibility testing, disk diffusion test, surveillance, antibiotic
resistance, zone histogram
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I N T R O D U C T I O N
Antimicrobial resistance surveillance is becoming
critical in a global situation of increased occur-
rence and spread of resistance genes among bac-
terial pathogens. Several surveillance programs
have been launched to meet the need for antimi-
crobial resistance information [1–4]. Such studies
are usually performed in one of two ways. One
method is to send all clinical isolates from parti-
cipating laboratories to a reference laboratory,
where antimicrobial susceptibility testing is per-
formed with a reference MIC method [1,2]. A
similar centralized approach, but using stand-
ardized disk diffusion testing, has also been
employed [5]. The TSN database [6,7], on the other
hand, represents a decentralized project, with test
results being produced in the individual labora-
tories, but compiled and analyzed centrally. Mil-
lions of susceptibility test results have thus been
aggregated, which gives an idea of the enormous
amount of antimicrobial susceptibility data avail-
able for surveillance, if these test results can be
made comparable.
In earlier investigations, we have studied ways
of calibrating the disk diffusion antimicrobial sus-
ceptibility test in order to improve accuracy and to
make results comparable. Two methods were
described [8,9]. The first method, called ‘peak-
corrected breakpoints’ or ‘control strain peak cor-
rection’, compares the reference strain zone values
from the reference authority issuing interpretive
breakpoints with the zone values produced in the
individual laboratory; a correction of the zone
breakpoints can then be made. Such a semicalibra-
tion reduced false-resistant interpretations from
4.4% to 2.3% [8]. Another method, called single-
strain regression analysis (SRA) [9,10], a true cali-
bration method, reduced false-resistant results
from 4.4% to 0.14% [8]. Neither of these methods,
however, lends itself to more widespread use for
surveillance. Recently, a method for normalized
interpretation of antimicrobial resistance has been
invented (G. Kronvall, Patent pending, Swedish
Patent Office, 2001-04-10, Appl. no. 0101251-7).
The method utilizes the fact that the normal, sus-
ceptible population of clinical isolates of any
species forms an antimicrobial inhibition zone his-
togram which is not influenced on the high-
zone side by an increase in the number of resistant
isolates in the same histogram. The mathema-
tical reconstruction of the normal, susceptible
population, which has been shown to follow
parametric criteria to a sufficient degree [11],
permits the setting of a lower limit for the sus-
ceptible population. This normalized resistance
interpretation requires a standardized disk test
but is independent of MIC limits used for setting
zone breakpoints, and other methodological var-
iations, and is therefore especially suited for
antimicrobial resistance surveillance. In the pre-
sent study, we have tested this new principle on
results from susceptibility tests of both control
strains and clinical isolates, and in laboratories
using the Swedish Reference Group for Antibio-
tics (SRGA) standard, or that of the National
Committee for Clinical Laboratory Standards
(NCCLS).
M A T E R I A L S A N D M E T H O D S
Bacterial strains, culture media, and species
identification
Staphylococcus aureus and Escherichia coli strains
were isolated and identified in clinical spe-
cimens by the use of standard methods [12–14].
The majority of the consecutive specimens
included comprised wound secretions and urine
samples. Control strains S. aureus ATCC 29213
and E. coli ATCC 25922 were tested regularly in
disk diffusion tests at the laboratories. Two
Swedish clinical microbiology laboratories parti-
cipated in the study, Karolinska Hospital (KS),
Stockholm Sweden, and Va¨xjo¨ General Hospital
(VX) Va¨xjo¨, Sweden. WHONET-filed results
were also available from two clinical microbiol-
ogy laboratories in Argentina (LabA and LabB),
and were used for comparisons with the Swedish
results.
Disk diffusion antimicrobial susceptibility
testing
The antimicrobial susceptibilities of clinical iso-
lates were determined by use of the disk diffusion
method according to the SRGA [15], with inter-
pretations adjusted for species groups (http://
www.srga.org) [9,16]. Bacterial strains were inocu-
lated on Oxoid Iso-Sensitest Agar (Oxoid Ltd,
Basingstoke, UK). Antibiotic disks were purchased
from Oxoid AB (Oxoid AB, Sollentuna, Sweden).
Antibiotic disks were placed on the inoculated
surface, followed by pre-diffusion at room tem-
perature for 30 min, and then by overnight
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incubation at 36 8C 1 8C in air. Inhibition zone
diameters were measured in millimeters with a
pair of calipers. The interpretation of susceptibility
followed species-related guidelines issued by the
SRGA [16]. The total numbers of disk test results
included in the present study were 114 217 for the
clinical isolates (KS 74 969; VX 39 248) and 3582 for
the ATCC strains (KS 840; VX 2742).
Antibiotic susceptibility testing in laboratories
in Argentina followed the NCCLS standard and
included regular testing of the control strains S.
aureus ATCC 29213 and E. coli ATCC 25922.
Results were entered into WHONET files with
zone diameter recordings included, comprising
a total of 8823 records.
Method for normalized resistance
interpretation
The method is based on analysis of zone diameter
histograms from individual laboratories for the
antibiotic disks used and for different bacterial
species separately (G. Kronvall, Patent pending,
Swedish Patent Office, 2001-04-10, Appl. no.
0101251-7). Zone diameter histograms for combi-
nations of antimicrobials and bacterial species
were constructed with percentage strains or num-
ber of strains on the y-axis against the zone dia-
meter values on the x-axis. Histograms for
normally susceptible isolates or control strains
show homogeneous populations that follow a
normal Gaussian distribution well, but with a
slightly peaked shape and a skew towards higher
zone values [11]. Parametric statistical measures,
the mean and standard deviation, have been
shown to describe these histogram populations
accurately [11]. When clinical isolates of any
combination of antibiotic and individual bacterial
species are analyzed similarly, the position of
the normally susceptible wild-type strains is
unchanged, whereas the resistant or intermedi-
ately resistant strains form more or less well-
defined populations at the lower end of the zone
diameter spectrum.
The basis for the present normalization proce-
dure is the fact that resistant isolates give inhibi-
tion zone diameters which are below those of the
susceptible population, often with no zone at all.
The high-zone side of the normal population of
susceptible strains therefore remains unchanged
by the occurrence of resistant isolates. This pro-
vides the internal reference that makes histograms
for the same combination of antimicrobial and
bacterial species from any laboratory comparable.
The first step in the reconstruction of the sus-
ceptible population is detection of the peak of the
susceptible strains. This is done by calculating
moving weighted averages of numbers of strains
for two or more zone diameter values, starting
from the high-zone values. When the averages
start to decrease, then the previous zone value is
taken as the peak of the susceptible population (for
averages of more than two zone diameter values, a
correspondingly higher zone diameter can be cho-
sen). The estimated total number of susceptible
strains in the reconstructed susceptible population
is then twice the number of strains down to the
peak zone value.
The next step is expression of the true number of
strains down to the peak value as the accumulated
percentage values of the estimated susceptible
population. These percentage values are then
transformed to probit values [17], and the linear
relationship between probit values and inhibition
zone values is calculated from the highest zone
down to the peak by use of the least-squares
method, giving the regression coefficients and
the product–moment correlation coefficient. The
mean value of the estimated susceptible popula-
tion and its standard deviation are thereby made
known, and the whole curve can be constructed.
Several of the parameters can be varied in this
procedure, if required. In preliminary experi-
ments, a weighted average based on two zone
diameter values was found to produce reliable
estimations, and was therefore chosen as a starting
parameter in the present investigations, but results
for averages based on three and four values were
also calculated. In the computer program, some
other corrections have also been included. Single
outliers (defined as single results with a gap of
3 mm to the next lower positive zone value) were
excluded from the normalization calculations. For
the straight-line determination of probit versus
zone diameter, the uppermost 2% are omitted in
the least-squares method, but included otherwise.
R E S U L T S
S. aureus ATCC 29213 and E. coli ATCC 25922
results
Reference strains S. aureus ATCC 29213 and E. coli
ATCC 25922 were tested routinely in the par-
ticipating laboratories for control purposes. The
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antibiotics included for testing the control strains
were identical in the two Swedish laboratories for
13 of 19 different combinations of antibiotic and
bacterial species. For validation of the normaliza-
tion procedure, 32 control strain histograms from
KS and VX were analyzed, and the mean values
and standard deviations were calculated. The his-
tograms were then analyzed by use of the new
normalized interpretation method, giving calcu-
lated mean values and standard deviations for the
ideal distributions. Examples of histograms with
true numbers of isolates as well as the correspond-
ing normalized distribution of isolates are shown
in Figure 1. On visual inspection, there was good
agreement between true histograms and the nor-
malized distributions.
A comparison between the true means and the
means of the normalized distributions was made,
and the results are shown in Figure 2. Since the
control strain histograms represent homogeneous
populations, the calculated ideal distributions
should follow these populations quite closely,
and these experiments therefore checked the valid-
ity of the normalization procedure. The results
showed a very close correlation between the true
means and the calculated ideal means, with a
Figure 1 Inhibition zone diameter
histograms for S. aureus ATCC
29213 tested 198 times against a 15-
mg erythromycin disk (a) and for E.
coli ATCC 25922 tested 50 times
against a 10-mg ampicillin disk (b).
Superimposed on the histograms are
the calculated curves for the distri-
butions according to the new nor-
malized interpretation method.
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correlation coefficient r¼ 0.998. The mean value of
the absolute numbers for the differences was
0.4 mm, and that for the true differences was
0.08 mm, which means that the calculated ideal
distributions followed the true histogram peaks of
the control strains very closely. Only one of 32
control strain histograms had a difference between
the true and calculated means of more than 1 mm.
A tentative limit for the susceptible population
set to three standard deviations below the calcu-
lated means would theoretically include 99.86% of
the susceptible population above this limit. The
calculated lower 3 SD limits for the individual
histograms were adjusted to nearest-integer
values, and the true populations of zone diameter
values for the control strains were then checked by
using these limits. Out of 3582 control strain
results, there were eight zone diameter recordings
below the calculated limits, i.e. 0.22% of the results.
This is a little higher than the theoretical value of
0.14%. An examination of the individual histo-
grams revealed that six of the eight deviations
came from one single histogram, the case already
noted above because of the difference between
the means. The two other random deviations
accounted for 0.06%, which is below the expected
theoretical 0.14%.
Analysis of clinical isolates of S. aureus and
E. coli
In total, 57 histograms from KS and VX with
114 217 test results were then analyzed for the
presence of inhibition zone values below a 3 SD
limit for the calculated normalized population of
susceptible isolates in the individual histograms.
The ideal distributions were determined by the
normalized resistance interpretation method with
a weighted average based on isolates for two zone
diameters, and also with elimination of outliers in
the calculations. Results for netilmicin, trimetho-
prim, co-trimoxazole and ciprofloxacin were avail-
able at both laboratories and for both species.
Ciprofloxacin 10-mg disks were used at KS,
whereas VX used 5-mg disks. Histograms for E.
coli and ciprofloxacin for the two laboratories are
shown in Figure 3. Normalized means for the
calculated ideal wild-type distributions were
39.3 mm at KS (2081 isolates, Figure 3a) and
35.4 mm at VX (4718 isolates, Figure 3b), respec-
tively, for E. coli and ciprofloxacin at the two
laboratories. The resistance levels among E. coli
strains (defined as ‘R þI’ combined) reported by
the laboratories were 25.8% and 2.5% at KS and
VX, respectively, and by the normalized interpre-
tation the figures obtained were 27% and 3.2%,
respectively.
Among antimicrobials used for both S. aureus
and E. coli in both laboratories, trimethoprim gave
histogram distributions which indicated many
resistant isolates. The results from trimethoprim
tests and normalized calculations are shown in
Figure 4. The calculated means for the normalized
distributions were, for S. aureus, 25.6 and 26.5 mm
for KS (Figure 4a) and VX (Figure 4b), respectively,
and for E. coli, 29.5 and 30.6 mm, respectively
Figure 2 Mean zone values for 32
histograms of S. aureus ATCC 29213
and E. coli ATCC 25922 and 18
different antimicrobials in two dif-
ferent microbiology laboratories
(regular mean values on the x-axis)
were plotted against the calculated,
normalized means of the same his-
tograms (normalized mean values
on the y-axis). The coefficient of
correlation was 0.998.
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(Figure 4c,d). Regular interpretations of resistance
(R þI categories combined) showed 4.2% and
7.7% for S. aureus and the respective laboratories,
and 42.1% and 13.0% for E. coli. The figures
obtained using the automatic normalized resis-
tance calculation were 4.2%, 8.3%, 42.4%, and
13.2%, respectively. These figures corresponded
well with the figures generated in the laboratories
using species-related interpretations according to
the SRGA.
The results from disk tests of S. aureus and E. coli
with the other antibiotics at KS and VX were also
analyzed, and a summary of the results is shown in
Tables 1 and 2. For the majority of combinations
analyzed, there was almost complete agreement
between the resistance rates reported (percentage
Rþ I) when using species-related interpretations
according to the SRGA and the calculated normal-
ized resistance interpretations (percentage n–R)
when using the new method (Tables 1 and 2).
Figure 3 Inhibition zone diameter
histograms for clinical isolates of E.
coli from disk diffusion tests with
ciprofloxacin at KS (10-mg disk) (a)
and at VX (5-mg disk) (b). The
calculated distributions using the
normalization procedure are shown
in the histogram plots.
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For E. coli and mecillinam at KS, the histogram
showed isolates with an unusually wide distribu-
tion of zone diameter values, without a distinct
separation of resistant isolates from susceptible
ones. The normalized resistance interpretation
produced a result, 13.7%, which was between
the 8.3% R and the 26.8% Rþ I values according
to the interpretations by the laboratories. There-
fore, the lack of separation of susceptible strains
from strains with resistance mechanisms makes
it difficult to apply the present method for mecil-
linam. This is not so apparent in the VX histogram,
since the number of resistant isolates was much
lower. For two S. aureus histograms at KS, those
for tetracycline and rifampicin, there were also
differences which showed up as inconsistent
results when the procedure for normalized inter-
pretation was carried out with averages based on
two, three and four zone diameter values, and the
results were therefore excluded. Our data sug-
gested that the normalized resistance inter-
pretation method produced results which were
Figure 4 Inhibition zone diameter
histograms for S. aureus (a,b) and
E. coli (c,c) clinical isolates from disk
diffusion tests with trimethoprim
(5-mg disk) at KS (a,c) and VX (b,d).
The calculated distributions ob-
tained using the normalization pro-
cedure are shown in the histogram
plots.
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consistent and reliable for comparative pur-
poses for 54 of the included 57 histograms of disk
diffusion test results for clinical isolates with
different combinations of bacterial species and
antbiotics.
The method of normalized resistance interpre-
tation was also tested in preliminary investigations
of histograms from two laboratories in Argentina
(LabA and LabB) that were using the NCCLS
standards for disk diffusion tests. The calculated
ideal distributions of susceptible strains showed
lower mean values in these laboratories than at KS
and VX, reflecting differences between the two
standards, such as differences in inoculum size.
In general, there were few resistant isolates in the
two laboratories in Argentina, and two repre-
sentative examples are shown in Figure 5b,d in
comparison with results from KS (Figure 5a,c). For
E. coli and imipenem, the resistance figure was
0% in both laboratories according to their own
Figure 4 continued
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KS VX
No. Rþ I n–R No. Rþ I n–R
Oxacillin 4398 5.6 5.6 1967 0.9 2.1
Gentamicin 3608 0.8 0.9
Netilmicin 821 1.2 1.3 109 0 0
Erythromycin 155 67.7 67.7 1813 6.8 7.4
Clindamycin 3570 4.3 4.3 1804 4.6 4.6
Fusidic acid 3605 3.8 5.9 1800 13.9 13.6
Chloramphenicol 278 3.2 2.5
Tetracycline 268 13.1 –
Rifampicin 814 2 – 109 3.7 3.7
Vancomycin 862 0 0 107 0 0
Norfloxacin 503 23.1 22.3
Ciprofloxacin 314 38.2a 38.2 326 11a 11
Nitrofurantoin 502 0.6 0.2 157 0 0
Trimethoprim 502 4.2 4.2 157 7.7 8.3
Co-trimoxazole 3565 0.8 1.2 1803 0.4 1.6
aNo susceptible category for this combination. The wild-type population is
designated intermediately susceptible. Only percentages of resistant (R) isolates
are included.
–, Discrepancies between results using averages based on isolates for two, three
and four zone diameter values, respectively, indicated irregular histogram
distributions. The histograms were not possible to interpret using the normal-
ization procedure, and the results were therefore excluded.
For information on SRGA guidelines, see http://www.srga.org
Table 1 Antimicrobial resistance
rates of S. aureus isolates according
to SRGA interpretations (percentage
Rþ I) and to automated, normalized
resistance interpretation (percentage
n–R)
KS VX
No. Rþ I n–R No. Rþ I n–R
Ampicillina 7207 56.1a 55.4 4732 18.1a 17.8
Mecillinam 5425 26.8 13.7 4449 9.4 11.3
Piperacillin 2176 37 36.5
Cefadroxila 4928 4a 3.6 4733 0.8a 0.4
Loracarbef 1684 7.9 7.3
Cefpirome 85 0 0
Ceftibuten 204 2 2
Cefuroxime 2182 9.9 8.3 187 6.9 2.1
Cefotaxime 2214 4.1 5.9 224 3.1 4
Ceftazidime 1368 6 5.1
Imipenem 1348 0.1 0.2 155 0 0
Gentamicin 2172 6.2 6.2
Amikacin 408 0.3 0.3
Netilmicin 410 1.2 1.4 290 0.3 0.3
Nalidixic acid 117 14.5 18.8
Norfloxacin 4919 14.7 12
Ciprofloxacin 2081 25.8 27 4718 2.5 3.2
Nitrofurantoin 4895 8 1.2 4450 0.7 0.6
Trimethoprim 6190 42.1 42.4 4437 13 13.2
Co-trimoxazole 1597 15.5 16.3 315 12.7 13.7
aNo susceptible category for this combination. The wild-type population is
designated intermediately susceptible. Only percentages of resistant (R) isolates
are included.
For information on SRGA guidelines, see http://www.srga.org
Table 2 Antimicrobial resistance
rates of E. coli isolates according to
SRGA interpretations (percentage
Rþ I) and to automated, normalized
resistance interpretation (percentage
n–R)
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Figure 5 E. coli clinical isolates
tested for susceptibility to imipenem
at KS (1348 isolates) and at LabB
(256 isolates), and to gentamicin at
KS (2172 isolates) and at LabA (272
isolates). Interpretive zone break-
points were S 23 mm, R 16 mm
(a), S 16 mm, R 13 mm (b), S
21 mm, R 17 mm (c), and S
15 mm, R 12 mm (c), respectively,
with calculated 3 SD limits of n–
R  2 7 m m , n – R  2 1 m m , n –
R 21 mm, and n–R 14 mm, re-
spectively. Bars denote clinical iso-
lates, and calculated distributions
are shown as lines.
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interpretations, and at KS and LabB, the figures
were 0.7% and 1.6% at KS and LabB, respectively,
according to normalized interpretations. For E.
coli and gentamicin, the figures were 5.6% and
8.8% according to the laboratories, and 6.8% and
9.9% according to the normalized interpretation
method.
D I S C U S S I O N
The need for global surveillance of antimicrobial
resistance has been recognized [18]. So far, how-
ever, this has not been realized to any appreciable
extent, mainly because the most commonly used
method for antimicrobial susceptibility testing, the
disk diffusion method, produces results in indivi-
dual microbiology laboratories that are not
directly comparable. When the methodologies
can be evaluated and are found to be similar, then
the results can be used for comparisons between
hospitals and countries [19]. This is, however, not
always the case. When some US laboratories were
studied recently for compliance with the NCCLS
standard, as few as 14.3% for Neisseria gonorrhoeae,
30.1% for Haemophilus influenzae and 41.6% for
Streptococcus pneumoniae followed the standard
[20]. Among Canadian laboratories, only 23 of
66 laboratories followed the NCCLS standard as
claimed [21]. In another investigation of 130
laboratories, all except one from outside of the
USA, the results from testing six distributed organ-
isms indicated problems [22]. It is therefore inter-
esting to note that a distinguished WHO expert
group, in its guidelines for surveillance, has advo-
cated standardization in order to make disk diffu-
sion test results comparable [23]. This would
actually mean that, for many years to come, it
would not be possible to obtain a full global
picture of antimicrobial resistance.
In the present study, a new method has been
tested for making disk diffusion test results com-
parable regardless of the standard used and inde-
pendent of differences in MIC limits or zone
breakpoints, and without any extra requirements
for the methodology other than measuring the
inhibition zones and recording the results. This
method is called normalized resistance interpreta-
tion, and it distinguishes the deduced population
of normal isolates from those with an increase in
resistance. The results of this approach are in some
ways similar to those of species-related interpreta-
tion, which was introduced in Sweden in the 1970s
and is now fully established, resulting in improved
accuracy of disk test results [16,24]. It was there-
fore appropriate to test the present method on
results from two Swedish laboratories (KS and
VX) which, in addition, differ in their rates of
antimicrobial resistance. The results showed very
good agreement between the reported levels of
resistance and the results from normalized resis-
tance interpretation (Tables 1 and 2). This method
therefore has the potential for more general use in
surveillance of antimicrobial resistance.
An irregularity of histograms frequently en-
countered is the well known fact that results for
even zone values are often higher than those for
odd zone values. This is illustrated in Figure 1b. If
the zone diameters for a given antibiotic disk are
Figure 5 continued
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quite large, then the zones of inhibition are often
incomplete, and the diameter has to be calculated
by doubling the radius, which, by necessity, gives
an even number. In such cases, values for odd zone
diameters are often absent. However, in the pre-
sent case (Figure 1b), the inhibition zones are
comparatively small, and the histogram might
therefore represent the fact that observers often
prefer even numbers if the measuring device
allows some degree of interpretation. This possible
explanation for uneven histograms, as well as
other subjective modifications of results, would
be avoided if some electronic reading device
was employed. Image processing of disk test
results has been possible for many years [25], but
recent improvements in technology have made
such equipment more suitable for laboratory use
on a wider scale [26,27].
For two of the 57 clinical isolate histograms of
antibiotic disk zone diameters and bacterial spe-
cies, the computer-generated results indicated that
the distribution of isolates was irregular and there-
fore did not permit a reliable calculation of the
normalized resistance rate (Tables 1 and 2). This
was evident from the divergent results based on
averages of two, three and four histogram bars for
the moving average. The discrepancy offers the
possibility, in future applications of the method, of
automatically excluding histograms that will not
provide reliable information.
There is a large and untapped source of infor-
mation regarding antimicrobial resistance rates in
disk diffusion test results available at local micro-
biology laboratories. Studies of centralized versus
local testing have indicated that routine disk diffu-
sion test results might be used for surveillance
under certain conditions [28]. It was once con-
cluded that disk tests are ‘deceptively easy to
perform’, and also that histograms collected in
different laboratories might be used for compara-
tive purposes, but no objective method for such an
analysis was presented [29]. The possibility of
using disk data for surveillance has been sug-
gested by O’Brien, who is the original inventor
of the WHONET computer program for recording
and analyzing disk diffusion test results [19,30,31].
We suggest that normalized resistance interpreta-
tion according to the present study and generated
by computer calculations should be tested on this
and other rich sources of information accumulated
through decades of meticulous recording in lab-
oratory databases [25].
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